May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Anatomical And Functional Outcome Of Macular Hole Surgery With And Without Autologous Platelet Concentrate
Author Affiliations & Notes
  • J. Kraus
    Department of Ophthalmology, University of Regensburg, 93051 Regensburg, Germany
  • J. Hillenkamp
    Department of Ophthalmology, University of Regensburg, 93051 Regensburg, Germany
  • C. Framme
    Department of Ophthalmology, University of Regensburg, 93051 Regensburg, Germany
  • A. Souka
    Department of Ophthalmology, University of Regensburg, 93051 Regensburg, Germany
  • H. Sachs
    Department of Ophthalmology, University of Regensburg, 93051 Regensburg, Germany
  • V.–P. Gabel
    Department of Ophthalmology, University of Regensburg, 93051 Regensburg, Germany
  • Footnotes
    Commercial Relationships  J. Kraus, None; J. Hillenkamp, None; C. Framme, None; A. Souka, None; H. Sachs, None; V. Gabel, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5803. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. Kraus, J. Hillenkamp, C. Framme, A. Souka, H. Sachs, V.–P. Gabel; Anatomical And Functional Outcome Of Macular Hole Surgery With And Without Autologous Platelet Concentrate . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5803.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To compare the anatomical and functional outcome of pars–plana–vitrectomy (ppV) with internal limiting membrane (ILM) peeling in macular hole surgery with and without platelet concentrate.

Methods: : Retrospective analysis of 74 patients with macular hole stage III or IV, who underwent ppV between 2000 and 2004. All patients were operated with indocyanine green assisted ILM–Peeling and gas tamponade. 28 patients (group 1) were operated with platelet concentrate, 46 patients (group 2) without platelet concentrate.

Results: : In group 1, the mean best corrected visual acuity (BCVA) improved from preop –0.78 LogMAR (min –1.60/max –0,30) to postop –0,62 LogMAR (min –1,60/max –0,10). In group 2, the mean visual acuity improved from preop –0,99 LogMAR (min –3,00/max –0,40) to postop –0,88 LogMAR (min –1,6/max 0,00). In group 1, 19 patients (67.9%) gained >= 1 line, 10 patients gained more than 3 lines (35.7%). 3 patients remained unchanged, 6 patients (21.4%) lost 1 line. In group 2, 24 patients (52.2%) gained >= 1 line, 13 patients (28.3%) more than 3 lines. 7 patients in this group remained unchanged (15.2%), 15 patients (32.6%) lost visual acuity, 6 patients (13.0%) more than 3 lines. In group 1, the macular hole closure rate was 100%. In group 2, the macular closure rate was 73.9%.

Conclusions: : The aid of autologous platelet concentrate appears to improve both the anatomical and the functional outcome of macular hole surgery with ILM–Peeling.

Keywords: retina • macular holes • vitreoretinal surgery 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×